Brad A. Lich
Brad A. Lich's purchase track record
Brad A. Lich has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/27/2025 | EMN | $225K | -9.9% | +12.5% | +7.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Eastman Chemical faces lower price targets from UBS, Mizuho, Citi. Three major banks recently lowered their price targets for Eastman Chemical, citing ongoing industry pressures. Despite these reductions, all firms maintained positive ratings on the stock. The company continues to offer a dividend yield of 3.86%, which remains a key feature for income-focused investors.
Transaction History
| SLGN | ▲ Buy | Grant | 3,254 | — | 5/27/2026 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 5,569 | $447K | 2/18/2026 | View on chart |
| EMN | ▲ Buy | Grant | 18,861 | $0 | 2/11/2026 | View on chart |
| EMN | ▲ Buy | Open Market | 3,280 | $225K | 8/27/2025 | View on chart |
| SLGN | ▲ Buy | Grant | 2,262 | — | 5/28/2025 | View on chart |
| EMN | ▼ Sell | Gift | 1,750 | $0 | 3/7/2025 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 6,167 | $638K | 2/18/2025 | View on chart |
| EMN | ▲ Buy | Grant | 19,331 | $0 | 2/18/2025 | View on chart |
| EMN | ▲ Buy | Option Exercise | 36,277 | $2.4M | 12/2/2024 | View on chart |
| EMN | ▼ Sell | Open Market | 36,277 | $3.8M | 12/2/2024 | View on chart |
| EMN | ▲ Buy | Option Exercise | 100 | $7K | 11/27/2024 | View on chart |
| EMN | ▼ Sell | Open Market | 100 | $11K | 11/27/2024 | View on chart |
| SLGN | ▲ Buy | Grant | 2,712 | — | 5/29/2024 | View on chart |
| EMN | ▼ Sell | Open Market | 23,028 | $2.3M | 5/15/2024 | View on chart |
| EMN | ▲ Buy | Option Exercise | 23,028 | $1.7M | 5/15/2024 | View on chart |
| EMN | ▲ Buy | Option Exercise | 11,922 | — | 3/1/2024 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 4,692 | $409K | 3/1/2024 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 3,338 | $274K | 2/14/2024 | View on chart |
| EMN | ▲ Buy | Grant | 13,352 | $0 | 2/14/2024 | View on chart |
| SLGN | ▲ Buy | Grant | 2,748 | — | 5/31/2023 | View on chart |
| EMN | ▲ Buy | Grant | 23,229 | $0 | 2/15/2023 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 7,471 | $666K | 2/15/2023 | View on chart |
| SLGN | ▲ Buy | Grant | 2,833 | — | 6/1/2022 | View on chart |
| EMN | ▲ Buy | Option Exercise | 5,961 | — | 3/1/2022 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 2,346 | $269K | 3/1/2022 | View on chart |
| EMN | ▲ Buy | Grant | 21,582 | $0 | 2/23/2022 | View on chart |
| EMN | ▼ Sell | Tax Withholding | 7,242 | $862K | 2/23/2022 | View on chart |
| EMN | ▼ Sell | Open Market | 3,393 | $392K | 8/27/2021 | View on chart |
| EMN | ▼ Sell | Open Market | 26,496 | $3.0M | 8/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
UBS Cuts Silgan Price Target to $38, Maintains Neutral Rating
UBS lowered its price target for Silgan Holdings to $38 while keeping a neutral stance. This move places the bank's outlook near the bottom of the current analyst range, which extends up to $61. The stock is currently trading below its 52-week high, reflecting broader market caution.
UBS Cuts Silgan Price Target to $38, Maintains Neutral Rating. UBS lowered its price target for Silgan Holdings to $38 while keeping a neutral stance. This move places the bank's outlook near the bottom of the current analyst range, which extends up to $61. The stock is currently trading below its 52-week high, reflecting broader market caution.